Matching, Outcomes and Costs in Substance Abuse/Psychiatric Treatment
NCT ID: NCT00012727
Last Updated: 2015-04-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
236 participants
INTERVENTIONAL
2001-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Medications for Opioid Use Disorders (MOUD) Via Telemedicine
NCT03566459
A Brief Values Intervention to Support Veterans in Early Buprenorphine Treatment
NCT05189223
Developing a Smartphone Application to Support Veteran Opioid Use Disorder Treatment
NCT06454903
Treatment for Psychological and Drug Abuse Problems
NCT01140334
Contingency Management for Stimulant Use Disorders
NCT05097547
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This project�s goal is to improve the quality of care and reduce treatment costs for veterans with substance abuse and psychiatric problems.
Objectives:
This project is evaluating a patient-treatment matching strategy to improve residential treatment for substance abuse patients with psychiatric disorders. Its immediate objective is to examine whether the matching strategy results in more effective and cost-effective treatment in VA programs. We hypothesize that patients with severe clinical problems will have better outcomes when they are matched to service-intensive programs; patients with moderate problems will have better outcomes when they are matched to programs having a lower intensity of services. For both patient groups, community treatment should prove to be more cost-effective than hospital treatment.
Methods:
The project utilized a stratified randomized design. We paired each of three VA hospital programs that treat dual diagnosis patients and are high on intensity with a nearby high-intensity community residential facility (CRF) that contracts with the VA. We also paired four VA hospital and four CRFs that are low on intensity. Veterans who applied for substance abuse treatment at VA facilities were randomly assigned to either the VA hospital or CRF. Patient assessments have been conducted at intake (N=230), discharge, and a 4-month follow-up. Primary outcomes are patients� severity of substance abuse and psychiatric problems. Secondary outcomes are patients� functional status and their VA and non-VA health care utilization and its costs.
Status:
Completed.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Arm 1
Matching Symptom Severity to Service Intensity
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Matching Symptom Severity to Service Intensity
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
US Department of Veterans Affairs
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Christine Timko, PhD
Role: PRINCIPAL_INVESTIGATOR
VA Palo Alto Health Care System, Palo Alto, CA
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
VA Long Beach Healthcare System, Long Beach, CA
Long Beach, California, United States
VA Palo Alto Health Care System, Palo Alto, CA
Palo Alto, California, United States
North Florida/South Georgia Veterans Health System, Gainesville, FL
Gainesville, Florida, United States
Omaha VA Nebraska-Western Iowa Health Care System, Omaha, NE
Omaha, Nebraska, United States
Oklahoma City VA Medical Center, Oklahoma City, OK
Oklahoma City, Oklahoma, United States
Hampton VA Medical Center, Hampton, VA
Hampton, Virginia, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Timko C, Sempel JM, Moos RH. Models of standard and intensive outpatient care in substance abuse and psychiatric treatment. Adm Policy Ment Health. 2003 May;30(5):417-36. doi: 10.1023/a:1024693614501.
Timko C, Sempel JM. Short-term outcomes of matching dual diagnosis patients' symptom severity to treatment intensity. J Subst Abuse Treat. 2004 Apr;26(3):209-18. doi: 10.1016/S0740-5472(04)00002-9.
Timko C, Lesar M, Calvi NJ, Moos RH. Trends in acute mental health care: comparing psychiatric and substance abuse treatment programs. J Behav Health Serv Res. 2003 Apr-Jun;30(2):145-60. doi: 10.1007/BF02289804.
Timko C, Lesar M, Engelbrekt M, Moos RH. Changes in services and structure in community residential treatment facilities for substance abuse patients. Psychiatr Serv. 2000 Apr;51(4):494-8. doi: 10.1176/appi.ps.51.4.494.
Timko C, Sempel JM. Intensity of acute services, self-help attendance and one-year outcomes among dual diagnosis patients. J Stud Alcohol. 2004 Mar;65(2):274-82. doi: 10.15288/jsa.2004.65.274.
Chen S, Barnett PG, Sempel JM, Timko C. Outcomes and costs of matching the intensity of dual-diagnosis treatment to patients' symptom severity. J Subst Abuse Treat. 2006 Jul;31(1):95-105. doi: 10.1016/j.jsat.2006.03.015.
Timko C, Yu K, Moos RH. Demand characteristics of residential substance abuse treatment programs. J Subst Abuse. 2000;12(4):387-403. doi: 10.1016/s0899-3289(01)00056-6.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IIR 95-011
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.